In Chapter 15 of Annex I to Regulation (EEC) No 2658/87, Additional note 2 is amended as follows:
Additional note 2.B.1 is amended as follows:
Point (a) is replaced by the following:
‘(a) one of the following wax contents:
a wax content not more than 300 mg/kg or
a wax content more than 300 mg/kg but not more than 350 mg/kg provided that:
the total aliphatic alcohol content is not more than 350 mg/kg or
the erythrodiol and uvaol content is not more than 3,5 %.’
Point (c) is replaced by the following:
‘(c) one of the following two characteristics:
a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;
a content in 2-glyceryl monopalmitate not more than 1,1 % if palmitic acid is not more than 14 % of the total content in fatty acids;’
Additional note 2.B.2 is amended as follows:
Point (ij) is replaced by the following:
‘(ij) one of the following two characteristics:
a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;
content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;’
Point (l) is replaced by the following:
‘(l) a content in stigmastadienes not more than 0,10 mg/kg;’
In additional note 2.C point (f) is replaced by the following:
‘(f) one of the following two characteristics:
a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;
a content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;’
In additional note 2.D points (a) – (d) are replaced by the following points (a) – (e):
‘(a) one of the following wax contents:
a wax content more than 350 mg/kg or
a wax content more than 300 mg/kg but not more than 350 mg/kg provided that:
the total aliphatic alcohol content is more than 350 mg/kg and
the erythrodiol and uvaol content is more than 3,5 %.
an erythrodiol and uvaol content more than 4,5 %;
a content in 2-glyceryl monopalmitate not more than 1,4 %;
the sum of transoleic isomers not more than 0,20 % and the sum of translinoleic + translinolenic isomers not more than 0,10 %;
a difference between the HPLC and theoretical content of triglycerides with ECN42 of not more than 0,6.’
In additional note 2.E the second sentence is replaced by the following:
‘Oils of this subheading must have a content in 2-glyceryl monopalmitate not more than 1,4 %, a sum of transoleic isomers of less than 0,4 %, a sum of translinoleic + translinolenic isomers of less than 0,35 % and a difference between the HPLC and theoretical content of triglycerides with ECN42 not more than 0,5.’